Marcia A Chan1, Christina E Ciaccio2, Nicole M Gigliotti1, Mo Rezaiekhaligh1, Jacob A Siedlik3, Kevin Kennedy4, Charles S Barnes1. 1. a Division of Allergy, Asthma and Immunology , Children's Mercy Hospital , Kansas City , MO , USA. 2. b Department of Pediatrics , University of Chicago Medicine, Comer Comer Children's Hospital , Chicago , IL , USA. 3. c Department of Exercise Science and Pre-Health Professions , Creighton University , Omaha , NE , USA. 4. d Center for Environmental Health, Children's Mercy Hospital , Kansas City , MO , USA.
Abstract
OBJECTIVE: Asthma is a common chronic childhood disease worldwide. Socioeconomic status, genetic predisposition and environmental factors contribute to its incidence and severity. A disproportionate number of children with asthma are economically disadvantaged and live in substandard housing with potential indoor environmental exposures such as cockroaches, dust mites, rodents and molds. These exposures may manifest through epigenetic mechanisms that can lead to changes in relevant gene expression. We examined the association of global DNA methylation levels with socioeconomic status, asthma severity and race/ethnicity. METHODS: We measured global DNA methylation in peripheral blood of children with asthma enrolled in the Kansas City Safe and Healthy Homes Program. Inclusion criteria included residing in the same home for a minimum of 4 days per week and total family income of less than 80% of the Kansas City median family income. DNA methylation levels were quantified by an immunoassay that assessed the percentage of 5-methylcytosine. RESULTS: Our results indicate that overall, African American children had higher levels of global DNA methylation than children of other races/ethnicities (p = 0.029). This difference was more pronounced when socioeconomic status and asthma severity were coupled with race/ethnicity (p = 0.042) where low-income, African American children with persistent asthma had significantly elevated methylation levels relative to other races/ethnicities in the same context (p = 0.006, Hedges g = 1.14). CONCLUSION: Our study demonstrates a significant interaction effect among global DNA methylation levels, asthma severity, race/ethnicity, and socioeconomic status.
OBJECTIVE: Asthma is a common chronic childhood disease worldwide. Socioeconomic status, genetic predisposition and environmental factors contribute to its incidence and severity. A disproportionate number of children with asthma are economically disadvantaged and live in substandard housing with potential indoor environmental exposures such as cockroaches, dust mites, rodents and molds. These exposures may manifest through epigenetic mechanisms that can lead to changes in relevant gene expression. We examined the association of global DNA methylation levels with socioeconomic status, asthma severity and race/ethnicity. METHODS: We measured global DNA methylation in peripheral blood of children with asthma enrolled in the Kansas City Safe and Healthy Homes Program. Inclusion criteria included residing in the same home for a minimum of 4 days per week and total family income of less than 80% of the Kansas City median family income. DNA methylation levels were quantified by an immunoassay that assessed the percentage of 5-methylcytosine. RESULTS: Our results indicate that overall, African American children had higher levels of global DNA methylation than children of other races/ethnicities (p = 0.029). This difference was more pronounced when socioeconomic status and asthma severity were coupled with race/ethnicity (p = 0.042) where low-income, African American children with persistent asthma had significantly elevated methylation levels relative to other races/ethnicities in the same context (p = 0.006, Hedges g = 1.14). CONCLUSION: Our study demonstrates a significant interaction effect among global DNA methylation levels, asthma severity, race/ethnicity, and socioeconomic status.
Entities:
Keywords:
DNA methylation; persistent asthma; race/ethnicity; socioeconomic status
Authors: Elissar Andari; Shota Nishitani; Gopinath Kaundinya; Gabriella A Caceres; Michael J Morrier; Opal Ousley; Alicia K Smith; Joseph F Cubells; Larry J Young Journal: Neuropsychopharmacology Date: 2020-01-13 Impact factor: 8.294
Authors: Maria Luisa Somoza; Natalia Pérez-Sánchez; José Antonio Cornejo-García; Gabriela Canto; Miguel Blanca; Isabel Torres-Rojas; Laura Martín-Pedraza; Natalia Blanca-López; Laura Victorio Puche; Eva Abel Fernández González; José Damián López Sánchez; Javier Fernández-Sánchez; Enrique Fernández-Caldas; Mayte Villalba; Francisco Javier Ruano Journal: J Asthma Allergy Date: 2022-09-26
Authors: Chris McKennan; Katherine Naughton; Catherine Stanhope; Meyer Kattan; George T O'Connor; Megan T Sandel; Cynthia M Visness; Robert A Wood; Leonard B Bacharier; Avraham Beigelman; Stephanie Lovinsky-Desir; Alkis Togias; James E Gern; Dan Nicolae; Carole Ober Journal: Epigenetics Date: 2020-09-30 Impact factor: 4.528